Inari Medical (NASDAQ:NARI) Earns Hold Rating from Analysts at Stifel Nicolaus

Stifel Nicolaus initiated coverage on shares of Inari Medical (NASDAQ:NARI – Free Report) in a research report released on Tuesday morning, Marketbeat.com reports. The firm issued a hold rating and a $50.00 price target on the stock. Several other equities analysts have also recently commented on NARI. Piper Sandler reiterated a neutral rating and set […]

Leave a Reply

Your email address will not be published.

Previous post Recon Technology (NASDAQ:RCON) Research Coverage Started at StockNews.com
Next post Oncolytics Biotech (NASDAQ:ONCY) Rating Reiterated by HC Wainwright